American Oncology Network Inc.
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, … Read more
American Oncology Network Inc. (AONC) - Total Assets
Latest total assets as of December 2024: $470.33 Million USD
Based on the latest financial reports, American Oncology Network Inc. (AONC) holds total assets worth $470.33 Million USD as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
American Oncology Network Inc. - Total Assets Trend (2020–2024)
This chart illustrates how American Oncology Network Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
American Oncology Network Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
American Oncology Network Inc.'s total assets of $470.33 Million consist of 70.5% current assets and 29.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 13.4% |
| Accounts Receivable | $189.63 Million | 40.3% |
| Inventory | $60.71 Million | 12.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.48 Million | 0.5% |
| Goodwill | $10.90 Million | 2.3% |
Asset Composition Trend (2020–2024)
This chart illustrates how American Oncology Network Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: American Oncology Network Inc.'s current assets represent 70.5% of total assets in 2024, an increase from 51.0% in 2020.
- Cash Position: Cash and equivalents constituted 13.4% of total assets in 2024, down from 51.0% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 40.3% of total assets.
American Oncology Network Inc. Competitors by Total Assets
Key competitors of American Oncology Network Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
American Oncology Network Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - American Oncology Network Inc. generates 3.74x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - American Oncology Network Inc. is currently not profitable relative to its asset base.
American Oncology Network Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.53 | 1.64 | 1.01 |
| Quick Ratio | 1.25 | 1.38 | 1.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $114.62 Million | $ 108.76 Million | $ 131.00 |
American Oncology Network Inc. - Advanced Valuation Insights
This section examines the relationship between American Oncology Network Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.24 |
| Asset Growth Rate (YoY) | 25.6% |
| Total Assets | $470.33 Million |
| Market Capitalization | $112.23 Million USD |
Valuation Analysis
Below Book Valuation: The market values American Oncology Network Inc.'s assets below their book value (0.24 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: American Oncology Network Inc.'s assets grew by 25.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for American Oncology Network Inc. (2020–2024)
The table below shows the annual total assets of American Oncology Network Inc. from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $470.33 Million | +25.60% |
| 2023-12-31 | $374.45 Million | +14.78% |
| 2022-12-31 | $326.23 Million | +31.39% |
| 2021-12-31 | $248.30 Million | +506268.92% |
| 2020-12-31 | $49.03K | -- |